Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Press Release NewsCunion Frames Its Wearable Health Ecosystem Around Five Health BenefitsMost health technology can overwhelm users with constant notifications and dashboards, eventually causing them to disengage. In response to this challenge, Cunion is building an ecosystem around the premise that the healthiest device is the one that stays quiet until it has something worth saying. From this approach, Cunion identifies five practical health benefits across its wearable ecosystem.To view an enhanced version of this...
- Woman Leaders AssociationWomen Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving WomenThe association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with clarity, confidence, and authenticity without sacrificing themselves in the process BOSTON, Aug. 29, 2026 -- The Women Leaders...
- AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology CongressAskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the presentation of baseline participant characteristics from GenePHIT, one of the largest randomized gene therapy trials conducted in heart failure to date. This presentation highlights the trial’s successful enrollment and further validates that multinational gene therapy trials of this size can be conducted. The Phase 2 clinical trial is evaluating the investigational one-time gene therapy umiposgene parvec (AB-1002) for its potential to improve cardiac function. Baseline characteristics from the trial are being presented at the European Society of Cardiology (ESC) Congress, which takes place in Munich, Germany, August 28–31, 2026.
- MeantMeant Earns LegitScript Certification for Its Online GLP-1 Weight Care PlatformMeant has earned LegitScript certification for its online GLP-1 weight-care platform, a step that reinforces the transparency behind how the service connects patients with licensed U.S. clinical oversight, private Care Coach support and ongoing...
- Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM
- INTCO MedicalINTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion PiecesINTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit...
- TakedaTakeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia VeraCompanies: Takeda Pharmaceutical CompanyOSAKA, Japan & CAMBRIDGE, Mass., August 28, 2026--Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer.
- Northeast Ohio Medical University (NEOMED) Mobilizes Global Health Resources for Nepal Disaster Response and RecoveryIn response to devastating events in Nepal that have severely damaged critical health care, water and community infrastructure, Northeast Ohio Medical University (NEOMED) is mobilizing its global health expertise, students, faculty and international partnerships to support urgent recovery efforts.
- American Pharmacists AssociationGlobal pharmacy leaders identify priorities for integrating pharmacists into primary health carePharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on advancing pharmacists' integration into primary health care, where they identified workforce readiness, sustainable funding models, supportive...
- Innolitics and BEACON-Neuro.AI Partner to Bring FDA Breakthrough Device BEACONPredict to MarketSAN FRANCISCO, August 28, 2026--Innolitics, a medical-device software and FDA regulatory services provider, and BEACON-Neuro.AI Inc., a Washington University in St. Louis startup, today announced the partnership behind BEACONPredict, AI software for predicting malignant cerebral edema risk after acute ischemic stroke. Innolitics brought the regulatory strategy and software engineering; BEACON-Neuro.AI brought the clinical science out of Dr.
- Doster Construction Company SalemDoster Breaks Ground on $78 Million Livingston Hospital Expansion in KentuckyDoster Construction has broken ground on a $78 million renovation and expansion project for Livingston Hospital in Salem, Kentucky, a major investment in the future of rural healthcare across Livingston County and the surrounding region.
- Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress